Bacteriocin: Curvalicin-28b

Default view

Bacteriocin: Curvalicin-28b

Accession: BAC004

Classification
Class: Unclassified
Genetics
Gene: Unidentified
Producer and target organisms
Description
Mode of action:
Bacteriocin active against Listeria monocytogenes. RANGE=1-10; NOTE=Ref.1.
Uniprot and PDB links

UniProt Entry: P84710

PDB EntryUnknown

PROTEIN SEQUENCE, FUNCTION, SUBCELLULAR LOCATION, AND MASS SPECTROMETRY, STRAIN=CWBI-B28
PubMed=16680519;DOI=10.1007/s10482-006-9063-0
Ghalfi H., Benkerroum N., Ongena M., Van Beuumen J., Wathelet B., Vandenberghe I., Bensaid M., Thonart P.
"Purification and characterization of three novel plasmid-born bacteriocins (curvalicins 28) produced by Lactobacillus curvatus CWBI- B28.", Antonie Van Leeuwenhoek 96(3):361-361(2009).
PROTEIN SEQUENCE, FUNCTION, SUBCELLULAR LOCATION, AND MASS SPECTROMETRY, STRAIN=CWBI-B28
DOI=10.1016/j.foodres.2009.08.009
Ghalfi H., Benkerroum N., Ongena M., Bensaid M., Thonart P.
"Production of three anti-listerial peptides by Lactobacillus curvatus in MRS broth.", Food Research International 43(1):33-39 (2010).
Loading...
End Note
Reference Manager
BibTeX
Protein sequence
 ........10 ........20 
          |          | 
 VAPFPEQFLX

Wheel representation
wheel representation of Curvalicin-28b
Protein sequence annotations
Features of Curvalicin-28b


FeaturePosition(s)LengthDescription
PEPTIDE1
Bioactive peptide 2.
Feature identifier = PRO_0000223896.
NON_TER10
Composition
Hydrophobicity

Composition
Formula C52 H72 N10 O12
Absent amino acids CDGHIKMNRSTWY
Common amino acids FP
Mass (Da) 1157.35
Net charge -1
Isoelectric point 3.85
Basic residues 0
Acidic residues 1
Hydrophobic residues 5
Polar residues 0
Aliphatic residues 2
Tiny residues 1
Boman Index 4.38
Hydropathy Index 0.52
Aliphatic Index 78
Instability Index 94.88 (unstable)
Half Life Mammalian : 100 hour
Yeast : >20 hour
E. coli : >10 hour
Extinction Coefficient 0 M-1 cm-1
Absorbance 280nm 0

Users comments for Curvalicin-28b

No comments found

Login or register to submit a comment for Curvalicin-28b.